---
title: "How Is The Market Feeling About Novartis?"
description: "Novartis's short percent of float has increased by 4.55%, with 4.38 million shares sold short, representing 0.23% of available trading shares. It would take traders an average of 1.88 days to cover th"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/253257264.md"
published_at: "2025-08-15T18:07:08.000Z"
---

# How Is The Market Feeling About Novartis?

> Novartis's short percent of float has increased by 4.55%, with 4.38 million shares sold short, representing 0.23% of available trading shares. It would take traders an average of 1.88 days to cover their short positions. An increase in short interest can indicate bearish market sentiment, while a decrease may suggest bullish sentiment. Compared to its peers, Novartis has a lower short interest at 3.24%. This trend does not necessarily predict a stock price decline in the near term.

Novartis's NVS short percent of float has risen 4.55% since its last report. The company recently reported that it has 4.38 million shares sold short, which is 0.23% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.88 days to cover their ...

### Related Stocks

- [NVS.US - NOVARTIS AG](https://longbridge.com/en/quote/NVS.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Novartis Vanrafia(R) Phase III data support slowing of kidney function decline in patients with IgA nephropathy | (MORE TO FOLLOW) Dow Jones Newswires February 13, 2026 01:15 ET (06:15 GMT) | [Link](https://longbridge.com/en/news/275856996.md) |
| Novartis reports final data of ALIGN trial in IgAN | Novartis has reported final data from the Phase III ALIGN trial, demonstrating that Vanrafia (atrasentan) significantly  | [Link](https://longbridge.com/en/news/276055699.md) |
| Short Interest in Schneider Electric SE (OTCMKTS:SBGSY) Drops By 16.8% | Schneider Electric SE (OTCMKTS:SBGSY) experienced a 16.8% decrease in short interest in January, with 197,858 shares sho | [Link](https://longbridge.com/en/news/276071356.md) |
| Assetmark Inc. Sells 82,501 Shares of Boston Scientific Corporation $BSX | Assetmark Inc. has reduced its stake in Boston Scientific Corporation (NYSE:BSX) by 41.6%, selling 82,501 shares in the  | [Link](https://longbridge.com/en/news/276044910.md) |
| Envestnet Asset Management Inc. Cuts Stock Position in Edwards Lifesciences Corporation $EW | Envestnet Asset Management Inc. reduced its stake in Edwards Lifesciences Corporation by 23.1% in Q3, now holding 261,58 | [Link](https://longbridge.com/en/news/275999995.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.